138 related articles for article (PubMed ID: 32359655)
1. Design of synthetic retinoids.
Chisholm DR; Whiting A
Methods Enzymol; 2020; 637():453-491. PubMed ID: 32359655
[TBL] [Abstract][Full Text] [Related]
2. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
3. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors.
LeMotte PK; Keidel S; Apfel CM
Biochim Biophys Acta; 1996 Mar; 1289(2):298-304. PubMed ID: 8600988
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
5. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
6. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
7. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
[TBL] [Abstract][Full Text] [Related]
8. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
9. [Retinoid antagonists].
Umemiya H; Kagechika H; Fukasawa H; Hashimoto Y; Shudo K
Yakugaku Zasshi; 1996 Dec; 116(12):928-41. PubMed ID: 8993231
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor.
Apfel CM; Kamber M; Klaus M; Mohr P; Keidel S; LeMotte PK
J Biol Chem; 1995 Dec; 270(51):30765-72. PubMed ID: 8530518
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic applications for ligands of retinoid receptors.
Thacher SM; Vasudevan J; Chandraratna RA
Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
[TBL] [Abstract][Full Text] [Related]
12. Novel synthetic retinoids and separation of the pleiotropic retinoidal activities.
Kagechika H
Curr Med Chem; 2002 Mar; 9(5):591-608. PubMed ID: 11945126
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
[TBL] [Abstract][Full Text] [Related]
14. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Makishima M; Shudo K; Honma Y
Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
[TBL] [Abstract][Full Text] [Related]
15. Retinoids selective for retinoid X receptor response pathways.
Lehmann JM; Jong L; Fanjul A; Cameron JF; Lu XP; Haefner P; Dawson MI; Pfahl M
Science; 1992 Dec; 258(5090):1944-6. PubMed ID: 1335166
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.
Boehm MF; McClurg MR; Pathirana C; Mangelsdorf D; White SK; Hebert J; Winn D; Goldman ME; Heyman RA
J Med Chem; 1994 Feb; 37(3):408-14. PubMed ID: 8308867
[TBL] [Abstract][Full Text] [Related]
17. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA.
Mouchon A; Delmotte MH; Formstecher P; Lefebvre P
Mol Cell Biol; 1999 Apr; 19(4):3073-85. PubMed ID: 10082574
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors.
Yang Y; Minucci S; Ozato K; Heyman RA; Ashwell JD
J Biol Chem; 1995 Aug; 270(31):18672-7. PubMed ID: 7629199
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
20. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
